Derek Erion is a seasoned professional in the pharmaceutical industry with extensive experience in strategic innovation and portfolio management, currently serving as the Strategic Innovation and Portfolio Management Lead in Cardiovascular, Renal and Metabolism at Roche since October 2025. Prior to this role, Derek held various leadership positions at Korro Bio, Inc., including Vice President and Senior Director from January 2021 to May 2025. Additionally, Derek held significant roles at Takeda as Director and Associate Scientific Director from October 2015 to January 2021, and previously worked at Pfizer as Principal Scientist and Senior Scientist between November 2010 and October 2015. Derek earned a Bachelor of Science in Molecular Biology, Biochemistry, and Chemistry from UC Irvine and a Doctor of Philosophy in Cellular & Molecular Physiology from Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices